Legal Notice: Levi & Korsinsky initiates securities fraud lawsuit against Semler Scientific, Inc.

Levi & Korsinsky have taken legal action against Semler Scientific, Inc., for alleged securities fraud, which has a deadline of October 28, 2025. The class-action lawsuit was brought forth by Levi & Korsinsky after conducting an investigation into potential securities law violations by Semler Scientific, Inc.

The lawsuit alleges that Semler Scientific, Inc., and its executives made false and misleading statements that led to inflated stock prices. These alleged misrepresentations are said to have caused financial harm to investors who purchased Semler Scientific, Inc. stock during the relevant period.

Semler Scientific, Inc. is known for providing technology solutions for the healthcare industry, specializing in diagnostic and monitoring equipment. The company’s products are designed to assist healthcare providers in managing patients with chronic diseases and identifying those at risk of developing complications.

Semler Scientific, Inc. has been under scrutiny due to its financial practices and disclosures. The class-action lawsuit seeks to hold the company accountable for any alleged violations of securities laws and to recover financial losses suffered by investors as a result of the alleged misconduct.

Investors who purchased Semler Scientific, Inc. stock between February 8, 2022, and September 3, 2025, are encouraged to participate in the class-action lawsuit. The lawsuit aims to provide an opportunity for affected investors to seek compensation for any losses incurred due to the alleged securities fraud perpetrated by Semler Scientific, Inc. and its executives.

Levi & Korsinsky are experienced in handling securities fraud cases and are committed to ensuring that investors have the opportunity to seek justice and recover losses resulting from alleged misconduct by companies and their executives. The deadline for investors to join the class-action lawsuit against Semler Scientific, Inc. is October 28, 2025.

The class-action lawsuit against Semler Scientific, Inc. is an important development in holding companies accountable for their actions and ensuring that investors are protected from fraudulent practices. Levi & Korsinsky will continue to investigate and pursue legal action against companies that are suspected of violating securities laws and misleading investors.

In conclusion, the securities fraud class-action lawsuit filed by Levi & Korsinsky against Semler Scientific, Inc. highlights the importance of transparency and accountability in the financial markets. Investors who believe they may have been affected by the alleged misconduct are encouraged to take action and seek compensation for any losses suffered. The deadline to join the class-action lawsuit is October 28, 2025, and Levi & Korsinsky are dedicated to advocating for the rights of investors and holding companies accountable for their actions.